| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Galecto, Inc. | Director | Stock Option (right to buy) | 720 | 18 Jun 2025 | Direct | ||
| ARENA PHARMACEUTICALS INC | Director | Common Stock | 0 | $98.51 | 11 Mar 2022 | Direct | |
| ARENA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | 11 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLTO | Galecto, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 07:00 |
| GLTO | Galecto, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:00 |
| GLTO | Galecto, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:00 |
| GLTO | Galecto, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 15 Jun 2022, 16:00 |
| /report/000162828022005908-dallas-jayson-donald-alexander-2022-03-11 | ARENA PHARMACEUTICALS INC | 11 Mar 2022 | 9 | $0 | 4 | Director | 11 Mar 2022, 15:22 |
| /report/000162828021012284-dallas-jayson-donald-alexander-2021-06-11 | ARENA PHARMACEUTICALS INC | 11 Jun 2021 | 3 | -$81,158 | 4 | Director | 15 Jun 2021, 17:27 |
| GLTO | Galecto, Inc. | 26 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 16:00 |